DK172477B1 - Fremgangsmåde til bestemmelse af risiko af Down's syndrom og analysemidler til anvendelse derved - Google Patents

Fremgangsmåde til bestemmelse af risiko af Down's syndrom og analysemidler til anvendelse derved Download PDF

Info

Publication number
DK172477B1
DK172477B1 DK198901154A DK115489A DK172477B1 DK 172477 B1 DK172477 B1 DK 172477B1 DK 198901154 A DK198901154 A DK 198901154A DK 115489 A DK115489 A DK 115489A DK 172477 B1 DK172477 B1 DK 172477B1
Authority
DK
Denmark
Prior art keywords
dheas
syndrome
hydroxy
assay
serum
Prior art date
Application number
DK198901154A
Other languages
Danish (da)
English (en)
Other versions
DK115489D0 (da
DK115489A (da
Inventor
Nicholas John Wald
Howard Stephen Cuckle
Jacob Abraham Canick
James Edward Haddow
Original Assignee
3I Res Expl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK172477(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878716158A external-priority patent/GB8716158D0/en
Priority claimed from GB878724913A external-priority patent/GB8724913D0/en
Application filed by 3I Res Expl Ltd filed Critical 3I Res Expl Ltd
Publication of DK115489D0 publication Critical patent/DK115489D0/da
Publication of DK115489A publication Critical patent/DK115489A/da
Application granted granted Critical
Publication of DK172477B1 publication Critical patent/DK172477B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Holo Graphy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK198901154A 1987-07-09 1989-03-09 Fremgangsmåde til bestemmelse af risiko af Down's syndrom og analysemidler til anvendelse derved DK172477B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8716158 1987-07-09
GB878716158A GB8716158D0 (en) 1987-07-09 1987-07-09 Antenatal screening for down's syndrome
GB878724913A GB8724913D0 (en) 1987-10-23 1987-10-23 Antenatal screening for down's syndrome
GB8724913 1987-10-23
GB8800557 1988-01-12
PCT/GB1988/000557 WO1989000696A1 (en) 1987-07-09 1988-07-11 Antenatal screening for down's syndrome

Publications (3)

Publication Number Publication Date
DK115489D0 DK115489D0 (da) 1989-03-09
DK115489A DK115489A (da) 1989-05-09
DK172477B1 true DK172477B1 (da) 1998-09-14

Family

ID=26292455

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198901154A DK172477B1 (da) 1987-07-09 1989-03-09 Fremgangsmåde til bestemmelse af risiko af Down's syndrom og analysemidler til anvendelse derved

Country Status (6)

Country Link
EP (1) EP0362294B1 (de)
JP (1) JP2525474B2 (de)
AT (1) ATE91182T1 (de)
DE (1) DE3882140T2 (de)
DK (1) DK172477B1 (de)
WO (1) WO1989000696A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666477B1 (de) * 1989-01-17 2003-10-15 JN Macri Technologies LLC, Inc. Einrichtung zum Nachweis vom Down syndrom durch nichtinvasive Siebtestung des mütterlichen Blutes
US5324667A (en) * 1989-01-17 1994-06-28 Macri James N Method for detecting down sydrown by non-invasive maternal blood screening
US5258907A (en) * 1989-01-17 1993-11-02 Macri James N Method and apparatus for detecting down syndrome by non-invasive maternal blood screening
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9306354D0 (en) * 1993-03-26 1993-05-19 Kodak Ltd Antenatal screening for chromosomal abnormalities
US5583612A (en) * 1994-07-14 1996-12-10 Xerox Corporation Flexible latch with relaxed engagement
GB9315230D0 (en) * 1993-07-22 1993-09-08 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9416415D0 (en) * 1994-08-13 1994-10-05 Kodak Ltd Antenatel screening for pregnacy abnormalities
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
KR100459271B1 (ko) * 2002-04-26 2004-12-03 엘지.필립스 엘시디 주식회사 구리 단일막 또는 구리 몰리브덴막의 식각용액 및 그식각방법
JP5636567B2 (ja) * 2010-10-13 2014-12-10 学校法人東京女子医科大学 脂肪性肝疾患を診断するためのバイオマーカー、その測定方法、コンピュータプログラム、および、記憶媒体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454232A (en) * 1982-06-07 1984-06-12 Bio-Rad Laboratories, Inc. Estriol assay
GR850899B (de) * 1984-04-12 1985-11-25 Gen Hospital Corp
US4670401A (en) * 1985-01-25 1987-06-02 Monell Chemical Senses Center Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators

Also Published As

Publication number Publication date
WO1989000696A1 (en) 1989-01-26
EP0362294B1 (de) 1993-06-30
DE3882140T2 (de) 1993-12-23
ATE91182T1 (de) 1993-07-15
EP0362294A1 (de) 1990-04-11
DK115489D0 (da) 1989-03-09
DE3882140D1 (en) 1993-08-05
JPH03502483A (ja) 1991-06-06
DK115489A (da) 1989-05-09
JP2525474B2 (ja) 1996-08-21

Similar Documents

Publication Publication Date Title
Birdir et al. Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy
DK172477B1 (da) Fremgangsmåde til bestemmelse af risiko af Down's syndrom og analysemidler til anvendelse derved
US6573103B1 (en) Antenatal screening for Down's syndrome
Hanita et al. Maternal level of pregnancy-associated plasma protein A as a predictor of pregnancy failure in threatened abortion
US5605843A (en) Kit for prenatal screening for Down's syndrome
Moreau et al. Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination
Lower et al. The value of serum levels of oestradiol, progesterone and β-human chorionic gonadotrophin in the prediction of early pregnancy loss
US7666683B1 (en) Rapid method of diagnosing a normal pregnancy with high accuracy
KR100389988B1 (ko) 임신이상에대한산전검사방법
US20070092445A1 (en) Assessing Ovarian Reserve
WO2006026243A2 (en) Inhibin-a: a marker for differentiation, diagnosing and screening abnormal pregnancies
US11255861B2 (en) Method for determining the risk of preterm birth
Westergaard et al. Placental protein measurements in complicated pregnancies. III. Premature labour
Lin et al. Prediction of early pregnancy outcomes
AU2002237407A1 (en) Improvements in or relating to assessment of fertility
Stener Jørgensen et al. Alpha‐fetoprotein and acetylcholinesterase activity in first‐and early second‐trimester amniotic fluid
RU2717148C1 (ru) Способ отбора женщин в группу риска по развитию рака молочной железы в перименопаузальном периоде
JP3440138B2 (ja) 染色体異常について妊娠期間中にスクリーニングするための方法および装置
Takata et al. Human chorionic gonadotropin in cervical fluid as a predictor of miscarriage
Krantz et al. First‐trimester maternal dried blood Down syndrome screening marker levels in early pregnancy loss
Alnakash et al. Outcome of the first trimester threatened miscarriage: study of the predicting factors
Navolan et al. Risk assessment program for fetal aneuploidies at the municipal clinical emergency hospital in Timisoara
Evans et al. Clinical usefulness of estriol assay for predicting" light-for-dates" infants.
Batlle et al. P07. 01: Patient's perception of first trimester risk assessment for Down syndrome: what is a “high risk” for you?
Miller et al. Citations from the literature

Legal Events

Date Code Title Description
PUP Patent expired